These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 9119739)
1. Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate. Nishiyama Y; Tanaka T; Naitoh H; Mori C; Fukumoto M; Hiai H; Toyokuni S Jpn J Cancer Res; 1997 Feb; 88(2):120-8. PubMed ID: 9119739 [TBL] [Abstract][Full Text] [Related]
2. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003 [TBL] [Abstract][Full Text] [Related]
3. Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Toyokuni S; Luo XP; Tanaka T; Uchida K; Hiai H; Lehotay DC Free Radic Biol Med; 1997; 22(6):1019-27. PubMed ID: 9034241 [TBL] [Abstract][Full Text] [Related]
4. Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats. Deguchi J; Miyamoto M; Okada S Jpn J Cancer Res; 1995 Nov; 86(11):1068-71. PubMed ID: 8567398 [TBL] [Abstract][Full Text] [Related]
5. Over-expression of glutathione S-transferase Yp isozyme and concomitant down-regulation of Ya isozyme in renal cell carcinoma of rats induced by ferric nitrilotriacetate. Tanaka T; Nishiyama Y; Okada K; Satoh K; Fukuda A; Uchida K; Osawa T; Hiai H; Toyokuni S Carcinogenesis; 1998 May; 19(5):897-903. PubMed ID: 9635880 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-alpha expression of renal proximal tubules in Wistar rats treated with ferric and aluminum nitrilotriacetate. Deguchi J; Kawabata T; Kondo A; Okada S Jpn J Cancer Res; 1993 Jun; 84(6):649-55. PubMed ID: 8340253 [TBL] [Abstract][Full Text] [Related]
7. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes. Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616 [TBL] [Abstract][Full Text] [Related]
8. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Toyokuni S; Mori T; Dizdaroglu M Int J Cancer; 1994 Apr; 57(1):123-8. PubMed ID: 8150530 [TBL] [Abstract][Full Text] [Related]
9. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Uchida K; Fukuda A; Kawakishi S; Hiai H; Toyokuni S Arch Biochem Biophys; 1995 Mar; 317(2):405-11. PubMed ID: 7893156 [TBL] [Abstract][Full Text] [Related]
10. Ferroptosis resistance determines high susceptibility of murine A/J strain to iron-induced renal carcinogenesis. Cheng Z; Akatsuka S; Li GH; Mori K; Takahashi T; Toyokuni S Cancer Sci; 2022 Jan; 113(1):65-78. PubMed ID: 34699654 [TBL] [Abstract][Full Text] [Related]
11. Stage-specific roles of fibulin-5 during oxidative stress-induced renal carcinogenesis in rats. Ohara H; Akatsuka S; Nagai H; Liu YT; Jiang L; Okazaki Y; Yamashita Y; Nakamura T; Toyokuni S Free Radic Res; 2011 Feb; 45(2):211-20. PubMed ID: 20942562 [TBL] [Abstract][Full Text] [Related]
12. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Li JL; Okada S; Hamazaki S; Ebina Y; Midorikawa O Cancer Res; 1987 Apr; 47(7):1867-9. PubMed ID: 3815378 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme. Fukuda A; Osawa T; Oda H; Toyokuni S; Satoh K; Uchida K Arch Biochem Biophys; 1996 May; 329(1):39-46. PubMed ID: 8619633 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Toyokuni S; Mori T; Hiai H; Dizdaroglu M Int J Cancer; 1995 Jul; 62(3):309-13. PubMed ID: 7628872 [TBL] [Abstract][Full Text] [Related]
15. Deletion and single nucleotide substitution at G:C in the kidney of gpt delta transgenic mice after ferric nitrilotriacetate treatment. Jiang L; Zhong Y; Akatsuka S; Liu YT; Dutta KK; Lee WH; Onuki J; Masumura K; Nohmi T; Toyokuni S Cancer Sci; 2006 Nov; 97(11):1159-67. PubMed ID: 16925583 [TBL] [Abstract][Full Text] [Related]
16. Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress. Athar M; Iqbal M Carcinogenesis; 1998 Jun; 19(6):1133-9. PubMed ID: 9667754 [TBL] [Abstract][Full Text] [Related]
17. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689 [TBL] [Abstract][Full Text] [Related]
18. Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress. Tanaka T; Kondo S; Iwasa Y; Hiai H; Toyokuni S Am J Pathol; 2000 Jun; 156(6):2149-57. PubMed ID: 10854235 [TBL] [Abstract][Full Text] [Related]
19. Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA). Randerath E; Watson WP; Zhou GD; Chang J; Randerath K Mutat Res; 1995 Feb; 341(4):265-79. PubMed ID: 7531286 [TBL] [Abstract][Full Text] [Related]
20. Renal carcinogenesis induced by ferric nitrilotriacetate in mice, and protection from it by Brazilian propolis and artepillin C. Kimoto T; Koya S; Hino K; Yamamoto Y; Nomura Y; Micallef MJ; Hanaya T; Arai S; Ikeda M; Kurimoto M Pathol Int; 2000 Sep; 50(9):679-89. PubMed ID: 11012980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]